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ABSTRACT Deposition of 13-amyloid peptide (A,B) in senile plaques is a hallmark of Alzheimer disease neuropathology.
Chronic exposure of neuronal cultures to synthetic AO is directly toxic, or enhances neuronal susceptibility to excitotoxins.
Exposure to A3 may cause a loss of cellular calcium homeostasis, but the mechanism by which this occurs is uncertain. In
this work, the acute response of rat hippocampal neurons to applications of synthetic A,3 was measured using whole-cell
voltage-clamp techniques. Pulse application of A,3 caused a reversible voltage-dependent decrease in membrane conduc-
tance. AO3 selectively blocked the voltage-gated fast-inactivating K+ current, with an estimated K, < 10 AuM. A,B also blocked
the delayed rectifying current, but only at the highest concentration tested. The response was independent of aggregation
state or peptide length. The dynamic response of the fast-inactivating current to a voltage jump was consistent with a model
whereby AO3 binds reversibly to closed channels and prevents their opening. Blockage of fast-inactivating K+ channels by AO
could lead to prolonged cell depolarization, thereby increasing Ca2+ influx.
INTRODUCTION
Deposition of f3-amyloid peptide (Af3) in fibrillar form into
senile plaques is a primary pathological feature of patients
with Alzheimer's disease. Transgenic mice have been de-
veloped that overexpress human A/3 precursor protein, se-
crete A,B, develop A,B amyloid deposits, and demonstrate
neuronal pathology and learning deficits (Games et al.,
1995; Moran et al., 1995). Neurotoxicity of A,3 to cortical
cultures has been demonstrated (Yankner et al., 1990). AP
may be directly toxic or may increase the vulnerability of
neurons to external insults (Koh et al., 1990; Cotman et al.,
1992; Loo et al., 1993; Busciglio et al., 1993). The mech-
anism(s) by which A,B mediates neurotoxicity is uncertain.
Several hypotheses have been put forth, including the fol-
lowing: A,3 generates free radicals, which oxidize mem-
brane proteins and lipids, thereby increasing membrane
permeability (Hensley et al., 1994); A,B forms a cation-
selective ion pore (Arispe et al., 1993); or Af3 causes a Ca21
influx or release of intracellular stores of Ca2+ (Mattson et
al., 1993). Incubation of human cortical cultures with A,B
led to increased intracellular Ca2+ and generalized loss of
Ca2+ homeostasis (Mattson et al., 1992). Ca2+ channel
blockers reduced toxicity of Aj3 in one study (Weiss et al.,
1994), but not in another (Whitson and Appel, 1995). A,B
also caused functional loss of 113-pS K+ channels in fibro-
blasts (Etcheberrigaray et al., 1994).
Typically, chronic incubation of A,3 with neurons for
several hours or days elicited the neurotoxic responses
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described above. Measurements of cellular properties after
long-term incubation of neurons with A,B may reflect a
cascade of responses of the cell to A,3, including new
protein synthesis or altered gene expression. Therefore,
these experiments do not reveal the immediate, acute effect
of AP interaction with neurons, which could then trigger
subsequent changes in neuronal functioning.
In work reported here, the acute response of rat hip-
pocampal neurons to A,B was assessed to elucidate the
initial steps in A,3 interaction with neurons. Whole-cell
voltage-clamp recordings were obtained from rat hippocam-
pal neurons before and after pulse application of AP. A,B
caused a voltage-dependent decrease in membrane conduc-
tance, indicating that the peptide affected functioning of a
voltage-gated channel. By evoking specific ion currents, we
show that AP3 selectively blocks the fast-inactivating K+
current.
MATERIALS AND METHODS
Materials
Peptides homologous to the first 39 and 40 residues of Af3, 13(1-39) and
13(1-40), respectively, were purchased from Anaspec (San Jose, CA).
Purity was assessed by amino acid analysis, mass spectrometry, and
reverse-phase chromatography. A peptide homologous to the first 28
residues of A,(3, /3(1-28), was synthesized and purified as described (Shen
et al., 1993). The N-terminal sequence Gln1 /-(l-16), the reverse sequence
peptide /3(40-1), and tetraethylammonium chloride (TEA) were purchased
from Sigma (St. Louis, MO). 632-microglobulin, 4-aminopyridine (4-AP),
and a-dendrotoxin (DTX) were purchased from Calbiochem (La Jolla,
CA).
Hippocampal neuronal cultures
Hippocampal cultures were prepared from Sprague-Dawley rats at postna-
tal day 0 or 1 as described (Trussell and Jackson, 1987) with minor
modifications. Briefly, animals were decapitated, and hippocampi were
removed quickly. Tissue was cut into small pieces, treated for 1 h at 320C
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in L-15 medium containing 0.5 mM EDTA, 1 mM cysteine, and 40 U/ml
papain at pH 7.2, then washed twice in papain-free L-15 solution contain-
ing 1 mg/ml ovomucoid and bovine serum albumin. Using fine-tipped
Pasteur pipettes, tissue was slowly triturated, and cells were spread onto
collagen-coated plates (Collaborative Biomedical Products, Bedford, MA).
Cells were maintained in minimum essential medium containing 6 mg/ml
glucose, 10% horse serum, 10% fetal calf serum, and antibiotics at 37°C
and 5% CO2. After glial cells covered the bottom of the culture dish (3-5
days), 80,uM 5-fluoro-2-deoxyuridine and 200 pM uridine were added to
the culture dish to prevent further glia proliferation. Hippocampal neurons
were cultured for a total of 3-10 days before use. Animals were handled
according to institutional guidelines under the university animal welfare
assurance program.
Voltage-clamp experiments
Whole-cell voltage-clamp recordings were obtained from rat hippocampal
neurons before and after pulse application of AP3. An Axopatch 200A
amplifier (Axon Instruments, Foster City, CA) was used for whole-cell
recordings. Currents were filtered at 5 kHz and digitized using a Digidata
1200 interface (Axon Instruments). For recordings, cells were bathed in a
room temperature (22°C) Ringer's solution (140 mM NaCl, 5 mM KCI, 3
mM CaCl2, 1 mM MgCl2, 20 mM glucose, and 10 mM HEPES, pH 7.3).
The recording pipette solution consisted of 130 mM KCI, 2 mM MgCl2, 2
mM ATP, 1 mM GTP, 5 mM EGTA, and 10 mM HEPES, pH 7.3. Data
were acquired and analyzed using pClamp (Axon Instruments).
Unless otherwise indicated, lyophilized peptides were dissolved at 10
mg/ml in 0.1% trifluoroacetic acid (TFA) for 1 h and then stored at -70°C
until use. Peptide stock solutions were thawed 24 h before use and diluted
to 10-4 M in Ringer's solution, and the pH was adjusted if required. Blue
food coloring dye (5-10% by volume) was added as a visible indicator. AP
was applied using a Picospritzer H from General Valve Corporation (Fair-
field, NJ). An initial control record was measured, and then 3(1-39) was
applied for 380 ms via a pressure pulse with a micropipette placed close
(30-50 ,um) to the clamped neuron. Delivery of the peptide to the clamped
neuron was confirmed by the presence of a pool of dye-colored fluid
surrounding the cell. The pool persisted for approximately 0.5-1 min. The
second current measurement was taken beginning 25 ms after pressure
ejection of AP3.
Current-voltage curves were measured from a holding potential of
-100 mV using a linear voltage ramp from -100 mV to +60 mV over 1.5
s. Specific ion currents were evoked as follows. The total K+ current was
evoked by holding the neuron at -100 mV for 380 ms and then stepping
to 0 mV for 50 ms. The delayed rectifying potassium current (IK) was then
evoked by stepping to 0 mV for 50 ms from a holding potential of -40
mV. In both cases 2 ,uM tetrodotoxin and 200 ,uM CdCl2 were added
extracellularly to block Na+ and Ca2+ currents, respectively. Control
experiments showed that Ca2+ currents were completely blocked under
these conditions (n = 5). The fast inactivating potassium current (IA) was
obtained by subtracting IK from the total K+ current (Ficker and Heine-
mann, 1992). Whether fast inactivating currents are functional in rat
hippocampal cells depends on a number of factors, including time in
culture (Ficker and Heinemann, 1992); only cells with both fast inactivat-
ing and delayed rectifying components of the K+ current were included in
the data analysis of potassium current effects. In some experiments, volt-
age-dependent K+ channel blockers TEA (10 mM), 4-AP (4 mM), or DTX
(100 nM) were added to the extracellular bath. In other experiments, the
voltage command paradigm was altered: the voltage was held at -100 mV
for 380 ms, then stepped to -40, -30, -20, -10, 0, 10, 20, 40, or 60 mV
to evoke the total K+ current. To evoke IK, a 50-ms voltage step to -40
mV was inserted after the activating voltage command of -100 mV. Na+
currents were evoked by holding the cell at -70 mV for 380 ms and then
stepping to -25 mV for 50 ms, with K+ currents blocked by substituting
130 mM CsCl for the KCI in the intracellular solution. Ca21 currents were
evoked by stepping the cell from a holding potential of -80 mV to 10 mV
for 50 ms, with K+ currents blocked by 130 mM intracellular CsCl and
Na+ currents blocked either by 2,uM extracellular tetrodotoxin or by
replacing NaCl in the extracellular solution with 140 mM choline chloride.
Leak currents were typically 1-4% of the total measured current and were
not subtracted.
RESULTS
A decrease in membrane conductance was observed for
61% of neurons (n = 18) in response to ,B(1-39) applica-
tion, as measured in voltage-ramp experiments (Fig. 1). A
neuron was considered to respond if the percentage change
in conductance after Af application exceeded that of the
largest percentage change in conductance observed when
solvent alone was applied. The membrane conductance was
calculated from the linear portion of the current-voltage
curve. In responding neurons, a 45 ± 10% decrease in the
membrane conductance was observed upon application of
(3(1-39), compared to a 5 ± 5% decrease observed after
application of the solvent vehicle (0.1% TFA diluted into
the recording bath (Ringer's) solution, n = 10). The mem-
brane conductance after application of A,B was voltage
dependent, suggesting that A13 alters the functioning of a
voltage-gated ion channel. The effect was reversible: after
diffusion of A,B away from the clamped cell, as assessed by
disappearance of the blue dye indicator, current-voltage
curves returned to the original (data not shown).
To identify the ion currents affected by AP3 application,
specific ion currents were evoked by voltage steps in the
presence of ion channel blockers. With Na+, K+, and Ca2+
currents blocked, only a small leak current was observed,
and the size of this current did not change with 13(1-39)
application (n = 3). When K+ currents were blocked, Na+
(n = 5) and Ca2+ (n = 6) currents with the expected time
and voltage dependencies were observed; these currents
were unchanged by ,B(1-39) application (data not shown).
With Na+ and Ca2+ currents blocked, application of (3(1-
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FIGURE 1 Representative measured current as a function of membrane
potential. Peptide concentration was 100 ALM in the application micropi-
pette. The voltage ramp used to elicit currents is shown; the bar indicates
A,Bpulse application. The Aj3 pool persists for approximately 30 to 60 s
after pulse application.
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39) resulted in significant decreases (60 ± 20%, mean ±
SD) in the fast-inactivating K+ current (IA) in 66% of cells
tested (n = 32). Fifty-nine percent of cells (n = 32) dis-
played a smaller but still significant decrease (40 ± 10%) in
the delayed rectifying K+ current (IK). Representative re-
cordings that illustrate these effects in a responder cell are
shown in Fig. 2. The mean decrease in current relative to
solvent alone reached statistical significance for IA (P <
0.0025) and for IK (p < 0.08) (Fig. 3). Both K+ currents
returned to their control levels after diffusion of AP3 away
from the cell (data not shown).
To determine the voltage dependence of the effect of A,B
on IA and IK' K+ currents were evoked at depolarizing
command potentials from -40 to +60 mV with Na+ and
Ca2+ currents blocked. IA was activated at slightly lower
membrane potential than IK, consistent with literature re-
ports (Ficker and Heinemann, 1992). The activation curves
for both IA and IK were unaffected by A,3 application (Fig.
4, A and B). The fractional reduction in IA and IK upon AP
application was not a function of the depolarizing potential
(Fig. 4 C), indicating that AP3 does not sense the electric
field in the pore.
The delayed rectifying current was sensitive to TEA
but insensitive to 4-AP and DTX at the concentrations
tested, whereas the fast-inactivating current was sensitive
to 4-AP and DTX but not to TEA. All tested cells were
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FIGURE 3 Mean change in specific ion currents after pulse application
of solvent (0.1% TFA diluted into Ringer's solution) or 100 ,uM /3(1-39).
Open bars, solvent; hatched bars, peptide. For IA and INa+, the ratio of the
peak current before A13 or solvent application to peak current after appli-
cation was reported; for IK and Ica2+, the ratio of steady-state values was
used. The error bars represent the standard error of the mean (n = 32 for
IA and IK' n = 5 for all others) of the ratios of currents before and after A(3
or solvent application. *, indicates the change in current is significantly
different from the change in current with solvent application (p < 0.08).
**, indicates current is significantly different from the change in current
with solvent application (p < 0.0025).
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FIGURE 2 Effect of AP3 on voltage-dependent K+ currents. (A, B, C) Representative recording from a responding cell of total (A), delayed rectifying
(B), and fast-inactivating (C) K+ current before A,B application. (D, E, F) Representative recording from a responding cell of total (D), delayed rectifying
(E), and fast-inactivating (F) K+ current after AP3 application. The fast-inactivating current was obtained by subtraction of the delayed rectifying from the
total K+ current, as described in Materials and Methods. The command potentials used to evoke total and delayed rectifying currents are shown. For
recordings from the cell in the presence of AP3, the peptide was applied for 380 ms at the beginning of the -100 mV activating voltage command. The
AP3 pool persists for approximately 30 to 60 s after pulse application. Leak currents were not subtracted.
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FIGURE 4 Voltage dependence of activation and of A,3 block of K+
currents. (A) Relative amplitude of fast-inactivating current as a function of
depolarizing command potential for cells before (-) and after (0) A,B
application. (B) Relative amplitude of delayed rectifying current as a
function of depolarizing potential for cells before (0) and after (0) A13
application. (C) Fractional reduction in IA (0) and IK (0) caused by A,3
application as a function of depolarizing potential. Results are mean ± SE
for seven cells.
sensitive to TEA or 4-AP, but only four of seven tested
cells responded to DTX. These results are in qualitative
agreement with previous reports on rat hippocampal CAl
neurons (Ficker and Heinemann, 1992; Halliwell et al.,
1986). TEA (10 mM) caused a 50 ± 30% decrease in IK
(n = 7). 4-AP (4 mM) caused a 70 ± 20% decrease in IA
(n = 7). In responding cells, DTX (100 nM) caused a 80
± 10% decrease in IA. For DTX-sensitive cells, the total
K+ current dropped to 50 ± 10% of its original value
after A13 application without DTX, but in the presence of
DTX A13 had a less pronounced effect, decreasing the
total K+ current to 70 ± 10% of its original value (p <
0.05). TEA and 4-AP had no statistically significant
effect on the reduction in total K+ current due to A13
application. Recordings from TEA- or DTX-treated cells
are shown in Fig. 5. The recordings illustrate the effects
observed on cells sensitive to both toxin and A13. TEA
reduced the delayed rectifying current but did not affect
the fast-inactivating current (Fig. 5 A). AP3 application to
this cell caused a similar loss of the transient K+ current
whether or not the cell was incubated with TEA. In
contrast, DTX caused a loss of the transient current in the
cell shown in Fig. 5 B; A,B had little additional effect.
The effect of A,B on IA and IK was concentration depen-
dent (Fig. 6 A). At concentrations of 10 ,uM or below in the
application micropipette, there was no effect of AP3 on IK.
Some reduction in IA was observed with pulse application
of A,B down to 1 ,tM in the micropipette. To test the effect
of peptide aggregation on neuronal response, ,3(1-39) was
dissolved in dimethyl sulfoxide (DMSO), diluted into Ring-
er's solution, and applied to the neuron within 2 h. We have
previously shown that under these conditions, the peptide is
less aggregated than when using our standard protocol of
predissolving in 0.1% TFA, diluting into Ringer's solution,
and incubating for 24 h before application (Shen and Mur-
phy, 1995). Response of the K+ current was independent of
the solvent used to predissolve ,3(1-39) (Fig. 6 A). There
was no effect of diluted DMSO on evoked currents (data not
shown).
The concentration dependence was fit assuming a simple
inhibition expression
(1)lo (1 fN)(KR +K[A1]) + fNR
where I or Io is the current after or before A13 application,
respectively, KI is the inhibition constant, [A13] is the con-
centration of peptide in the application micropipette (ex-
pressed in units of peptide monomer), andfNR is the fraction
of nonresponding channels. For the fast-inactivating K+
current, K, andfNR were estimated to be 10 ± 4 p,M and
0.4 ± 0.1, respectively. The actual concentration detected
by the neuron is lower than the concentration in the mi-
cropipette. Therefore, the calculated K, represents an upper
limit of the true constant.
13(1-28) and 1(1-40) evoked effects on IA and IK
similar to those of 13(1-39) (Fig. 6 B). Application of the
reverse sequence peptide 13(40-1) caused a 40 ± 10%
decrease in IA but did not affect IK. In control experi-
ments, the N-terminal A1B fragment Gln' ,'(1-16), 132-
microglobulin (a 12 kDa amyloidogenic protein with
high 13-sheet content; Gorevic et al., 1985), or bovine
serum albumin (data not shown) did not decrease evoked
currents significantly.
We considered several alternative mechanisms by
which A13 could reduce the fast-inactivating K+ current,
including: 1) A13 binds reversibly to closed channels to
prevent them from opening, 2) A13 binds reversibly to
open channels and increases their rate of deactivation,
and 3) A,3 irreversibly blocks open channels. To evaluate
these alternatives, the response of fast-inactivating K+
channels to a depolarizing step in the absence of A13
application was modeled assuming C => 0 > D, where
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FIGURE 5 Effect of pharmaco-
logical agents on A13-mediated
block of K+ currents. (A) Record-
ing from a cell treated with TEA.
The initial portion of the top re-
cording is of the evoked total and
delayed rectifying current before
A13 or TEA application. The break
in the recording indicates the time
during which AP was applied to the
cell. No change in measured current
was observed during this period.
The second portion of the top re-
cording is of the evoked total and
delayed rectifying current after Af3
application. The lower recording
was made in an identical fashion
from the same cell, taken 15-20
min after addition of TEA to the
extracellular medium. (B) Record-
ing from a DTX-sensitive cell. The
top recording is from a cell before
DTX addition, before (left) and af-
ter (right) A,B application. The lower
recording is taken from the same cell
15-20 min after addition of DTX to
the extracellular medium.
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C, 0, and D are the number of closed (and activated),
open, or deactivated channels, respectively. For simplic-
ity, all closed but activated states were lumped together.
The current was assumed to be directly proportional to
the number of open channels. A kinetic equation was
derived using first-order rate constants ko and kd for
opening and deactivating steps, respectively. For the base
case (no Af applied),
O*A,3 < D + AP, where O*AP3 is an open channel with
bound A,. The kinetic equation becomes
IA
Imax
K1 + [A _ _ _ko
K*KI(AP]
_
k (K + [AP3])
IA (k ko )(exp(-kt) - exp(-kdt)) (2)
'max d ko
where IA is the transient current through fast-inactivating
K+ channels and Ima is the maximum current if all channels
are open.
For case (1), an additional equilibrium binding step of C
+ A,B X B, where B is a blocked channel, was incorporated
into the model, or,
IA (K, ])(k k)(exp(-kot) - exp(-kdt)) (3)
where KI is the dissociation equilibrium constant. For case
(2), binding of A,B to an open channel was assumed to be at
equilibrium at all times and deactivation was modeled as a
first-order rate process. This was expressed as 0 + AP3 <
(4)
X (exp(-kot) - exp(-(K + [A,])(kd + k )) )
where k* is the deactivation rate constant for the open
channel with AP3 bound. For case (3), blocking was
modeled as 0 + AB => B, yielding
IA ( ko
Imax kd + kb[A1] - ko
X (exp(-kot) - exp(-(kd + kb[A1])t)) (5)
where kb is the rate constant for blocking of open channels
and A,3 is assumed to be in excess.
ko and kd were obtained by nonlinear regression fit of Eq.
2 to a representative recording before ,B(I-39) application
and used for all cases. For cases (1) and (2), KI was obtained
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FIGURE 6 Concentration and sequence dependence of current inhi-
bition by A,3. Current ratios were calculated as described in Fig. 3. Data
include both responder and nonresponder cells. (A) (3(1-39) was pre-
pared either by dissolving lyophilized peptide in 0.1% TFA, diluting
into Ringer's solution, and incubating for 24 h (filled symbols), or by
dissolving lyophilized peptide in DMSO, diluting into Ringer's solu-
tion, and using within 2 h (open symbols). Whole cell recordings of IK
(U or El) and IA (-or 0) were made from five to eight cells at each
concentration, except at 100 ,uM, where 32 cells were tested. The
concentration reported is the concentration in the application pipette.
Curves were fit by nonlinear regression to Eq. 1. (B) Whole cell
recordings of potassium currents were made from six to nine cells
before and after application of a 100 AM solution of each of the test
proteins or peptides, except for (32-microglobulin (032m), which was at
50 AM. The exact concentration of (3(40-1) is ambiguous because of
solubility limitations of the peptide in Ringer's solution. *, indicates
that the change in current is significantly different from the change in
current with solvent application (p < 0.01).
from the fit of concentration data to Eq. 1. k* (case 2) or kb
(case 3) was obtained by nonlinear regression fit of the data
at 10 ,uM (3(1-39) to Eq. 4 or 5, respectively. Response
curves were calculated for cases (1), (2), and (3) as a
function of A,3 concentration and compared to experimental
data (Fig. 7). In the experimental data, the peak height
decreases with increasing AP3 concentration, but the peak
position is unaffected by AP3. The shape of the experimental
curves, the peak positions, and the dependence of peak
height on A,B concentration are most closely captured by the
case 1) model.
DISCUSSION
Pulse application of A,3 caused a voltage-dependent de-
crease in membrane conductance of hippocampal neurons,
indicating that the peptide affected functioning of a voltage-
gated ion channel. A,B did not form a pore in the membrane.
Our results are contrary to reports of AB-mediated pore
formation in lipid bilayers (Arispe et al., 1993), or A(3-
mediated increases in membrane conductance and loss of
voltage-gating characteristics in bullfrog sympathetic gan-
glia (Simmons and Schneider, 1993). The reasons for these
differences are unknown, but we note that hippocampal
neurons comprise a different model system than artificial
lipid bilayer membranes or sympathetic ganglia, and that
the latter investigators used the short peptide (3(25-35)
rather than the full-length A,B peptide. In addition, using our
experimental protocol, cells were exposed to A,B for a
shorter period of time and current measurements were taken
within several milliseconds after A,B application.
Specific ion current experiments isolated this effect to
blockage of a voltage-dependent K+ current. The fractions
of responding cells in experiments using the voltage-ramp
and voltage-step paradigms were similar, as were the frac-
tional decreases in membrane conductance and total K+
current upon AP3 application, further indicating that the
decrease in the membrane conductance is attributable pri-
marily to a decrease in K+ outward flux. The decrease in the
fast-inactivating current was greater, and persisted to lower
concentrations, than the decrease in the delayed rectifying
current. The effect is unlikely to be due to Ca2+-activated
K+ channels, because Cd2+ effectively blocked Ca2+ entry,
EGTA was added in the recording pipette as a divalent ion
chelating agent, and almost all Ca2+-activated K+ channels
are noninactivating. Pharmacological assays suggested that
the channel(s) affected by AP3 are DTX sensitive. Taken
together, these data indicate that the primary acute effect of
A,B on ion channels in rat hippocampal neurons is blockage
of voltage-gated fast-inactivating DTX-sensitive K+ chan-
nels.
Blocking efficacy was unaffected by changes in the de-
polarizing potential, implying that A(3 does not sense the
electric field. Therefore, if A,B blocks via binding to channel
proteins, it likely binds to an external site rather than in-
serting into the pore. DTX, which binds to a negatively
charged region near the external mouth of the K+ channel
pore, also blocks in a voltage-independent manner (Hurst et
al., 1991).
The decrease in IA was concentration dependent, with a
fitted KI ,uM. The actual concentration detected by the
neuron is estimated to be approximately tenfold lower than
the concentration in the micropipette. Thus, the calculated
KI represents an upper limit of the true constant. For com-
parison, in vitro neurotoxic effects are generally detectable
at A,B concentrations of 1-20 ,uM (Cotman et al., 1992; Loo
et al., 1993; Busciglio et al., 1993; Mattson et al., 1993).
The independence of the effect on aggregation state was
unexpected because in vitro measurements of peptide tox-
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FIGURE 7 Model predictions of effect of A13
on fast inactivating potassium current. The upper-
most curve represents the current before A,B ap-
plication. Curves of decreasing amplitudes repre-
sent currents upon application of 10 A.&M, 20 ,uM,
and 100 ,IM l3(1-39), respectively. (A) Represen-
tative recordings from responding cells. (B) Cal-
culated response curve for case (1): AJ3 binds
reversibly to a closed channel and blocks it. (C)
Calculated response curve for case (2): A,B binds
reversibly to an open channel and increases the
rate of deactivation. (D) Calculated response
curve for case (3): AJ3 binds irreversibly to an
open channel and blocks it.
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icity correlate with increased peptide aggregation (Pike et
al., 1993). Dependence of toxicity on aggregation state in
long-term cultures could be influenced by such factors as
persistence of aggregated peptide because of increased re-
sistance to proteolysis (Tennent et al., 1995), or enhanced
association of aggregated peptide with cellular membrane
components (Good and Murphy, 1995). Thus, the acute
response that we observe may be necessary but not suffi-
cient for neurotoxicity. Cellular dysfunction and death may
require additional factors, such as formation of high con-
centrations of stable fibrillar aggregates.
13(1-28) and 13(40-1) were similar in effectiveness to
,1(1-39) and ,3(1-40) in blocking K+ currents. 13(1-28), the
N-terminal fragment of A13 that is extracellular in the pre-
cursor protein, is considerably less toxic to cultured neurons
than 13(1-40) (Yankner et al., 1990). 13(1-28) aggregates
into amyloid fibrils (Kirschner et al., 1987), albeit at higher
concentrations than the longer A13 forms (Burdick et al.,
1992; Shen et al., 1993). The reverse sequence peptide
13(40-1) was as toxic as 13(1-40) in one study (Giordano et
al., 1994), although two other studies reported that ,1(40-1)
was not neurotoxic (Busciglio et al., 1993; May et al.,
1993). 13(40-1) retains the amphiphilic and 13-sheet charac-
ter of 13(1-40) but forms amorphous rather than fibrillar
aggregates (Fraser et al., 1992).
Antiparallel 13-sheet structure is a common denominator
for many K+ channel toxins, including DTX (Skarzynski,
1992; Garcia et al., 1994; Johnson and Sugg, 1992). Elec-
trostatic interactions between basic residues (Lys and Arg)
in the toxins with acidic residues in the channel mouth
appear to mediate binding of many K+ channel blockers
(Hurst et al., 1991; Park and Miller, 1992; Smith et al.,
1993). All A,8 peptides that blocked the fast inactivating K+
current have the same basic residues (Arg5, Lys16, Lys28),
20 40 0 20 40
Time (ms)
and all can form ,3-sheet containing aggregates. GIn' '13(1-
16), which had no effect on K+ currents, is predominantly
random coil and lacks the important 14-28 sequence, which
confers amyloid fibril-forming capability (Gorevic et al.,
1987). ,B2-microglobulin, which is predominantly 13-sheet
but has a different size and charge distribution, also had no
effect on K+ currents. The results observed here may sug-
gest that 13-sheet structure and basic residues are important
in blocking the transient K+ current, but that neurotoxicity
after chronic exposure to A,B may require other factors in
addition, such as fibrillar structure.
Our interpretation of these results is that A13 acts
selectively, rapidly, and reversibly to block fast-inacti-
vating K+ channels. A13 blocks the delayed rectifying K+
channel but with less potency. A,1 does not alter the
gating properties of the channel (Fig. 4) or the kinetics of
channel opening (Fig. 7). Rather, our modeling suggests
that A,B reversibly binds to closed channels and prevents
them from opening.
These results are the first indication of an acute re-
sponse of neurons to A13 by blockage of K+ channels.
Fast-inactivating potassium channels are important in
modulating neuronal excitability. Blockage of K+ chan-
nels in hippocampal neurons causes Ca2+ influx and
accumulation of intracellular Ca2+ during synaptic stim-
ulation (Jaffe et al., 1994). Blocking the fast-inactivating
K+ channel with DTX facilitates Ca2+ entry, increases
cell excitability, causes convulsions, and increases neu-
rotransmitter release (Halliwell et al., 1986; Bagetta et
al., 1994). Very recently it has been shown that A,1
increases cell excitability and causes a rise in intracellu-
lar Ca2+ in hippocampal neurons (Brorson et al., 1995)
and that anticonvulsants reduce A13 neurotoxicity (Mark
et al., 1995). Elevated intracellular Ca2+ can alter cell
302 Biophysical Journal
Good et al. ,B-Amyloid Blocks K+ Current 303
function and lead to cell damage by multiple pathways,
including induction of apoptosis, abnormal membrane
permeability, damage to cytoskeleton, protein phosphor-
ylation, and production of free radicals (Siesjo, 1994;
Franklin and Johnson, 1994). Thus, we hypothesize that
AP-mediated neurotoxicity is initiated by blockage of
fast-inactivating K+ channels, leading to increased Ca2+
influx, intracellular Ca2+ accumulation, and neurotrans-
mitter release, thus beginning a cascade of subsequent
cellular responses that eventually result in neuronal dys-
function and death.
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